Rating History for Phathom Pharmaceuticals (PHAT) by Goldman Sachs

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/12/2021 Paul Choi Upgrade Neutral
(Sell)
48.00
(40.00)
32.97
(34.54)
4.76% Details